Florian Moik

33 posts

Florian Moik

Florian Moik

@FlorianMoik

Vienna, Austria Katılım Mart 2020
224 Takip Edilen63 Takipçiler
Florian Moik retweetledi
Simon Kraler
Simon Kraler@KralerSimon·
Check out our #ESCCongress 2024 simultaneous #CardioOncology publication on a novel risk score for MACE in cancer patients - now online @JTHjournal jthjournal.org/article/S1538-… Lucky me to have such a great team! Many thanks to @liberale_luca @Cihan_Ay_MD @FlorianMoik @TomLuscher
Simon Kraler tweet media
JTH@JTHjournal

Join #ESCardio oral session NOW: ‘Risk prediction and treatment options in cardio-oncology’ ▶️Simultaneous publication with @escardio congress: @KralerSimon & @FlorianMoik report on a novel risk score to predict cardiovascular risk in #cancer patients Look out for the paper, coming soon!! #Cardiotwitter

English
1
10
20
2.3K
Florian Moik retweetledi
JTH
JTH@JTHjournal·
Join #ESCardio oral session NOW: ‘Risk prediction and treatment options in cardio-oncology’ ▶️Simultaneous publication with @escardio congress: @KralerSimon & @FlorianMoik report on a novel risk score to predict cardiovascular risk in #cancer patients Look out for the paper, coming soon!! #Cardiotwitter
JTH tweet media
English
2
5
9
4.9K
Florian Moik retweetledi
Luca Liberale
Luca Liberale@liberale_luca·
Join us right now at Science Box 4 #ESCCongress as @KralerSimon present our results on CV risk stratification in patients with cancer. A great collaboration @UniGenova @cmc_uzh @MedUni_Wien @FlorianMoik @CarboneF82 @DavideRamoni @Cihan_Ay_MD @wenzl_florian @TomLuscher
JTH@JTHjournal

Join #ESCardio oral session NOW: ‘Risk prediction and treatment options in cardio-oncology’ ▶️Simultaneous publication with @escardio congress: @KralerSimon & @FlorianMoik report on a novel risk score to predict cardiovascular risk in #cancer patients Look out for the paper, coming soon!! #Cardiotwitter

English
0
6
7
1.1K
Florian Moik retweetledi
Jakob M. Riedl
Jakob M. Riedl@JakobMRiedl·
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study jitc.bmj.com/content/11/12/… Happy to share our recently published article!
English
1
3
6
414
Florian Moik retweetledi
Center for Molecular Cardiology
Center for Molecular Cardiology@cmc_uzh·
Now up @JTHjournal GDF-15 improves CV risk assessment, but predictive utility in cancer patients remained unknown 👉 doi.org/10.1016/j.jtha… Thank you @Cihan_Ay_MD @FlorianMoik for the fantastic collaboration @KralerSimon @TomLuscher @UZH_en @isth @MedUni_Wien @ELS_Cardiology
JTH@JTHjournal

GDF-15, thrombosis & #cancer: New insights show GDF-15, a #cardiovascular risk biomarker, is strongly linked to all-cause mortality in cancer patients, yet fails to improve #VTE prediction models. Learn more: #Thrombosis #CancerResearch bit.ly/3MIi4NQ

English
1
5
8
2.4K
Florian Moik retweetledi
Cihan Ay
Cihan Ay@Cihan_Ay_MD·
The interrelation between cancer and haemostatic system is multifaceted. @FlorianMoik presents an overview at #ASH22 in the Friday special symposium on cancer and malignancy. @ASH_hematology
Cihan Ay tweet mediaCihan Ay tweet media
English
2
8
28
0
Florian Moik retweetledi
Cihan Ay
Cihan Ay@Cihan_Ay_MD·
Comprehensive analysis of venous and arterial thrombosis in patients with cancer treated with targeted anti-cancer therapies. Collaborative work presented by @FlorianMoik at #ISTH2021. Causality or reflection of underlying tumor-type specific risk? @dceaarhus @ToftSorensen @isth
Cihan Ay tweet mediaCihan Ay tweet mediaCihan Ay tweet mediaCihan Ay tweet media
English
0
12
33
0
Florian Moik retweetledi
Jakob M. Riedl
Jakob M. Riedl@JakobMRiedl·
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line... sciencedirect.com/science/articl… Happy to share our study which demonstrates similar effectiveness for Gemcitabine/nab-Paclitaxel and FOLFIRINOX for palliative first line treatment in advanced pancreatic cancer
English
0
1
4
0
Florian Moik retweetledi
Cihan Ay
Cihan Ay@Cihan_Ay_MD·
Thrombosis is common in cancer pts treated with immune checkpoint inhibitors. Was not reported in registration trials. Just reflecting baseline risk of thrombosis in cancers treated with these new anti-cancer treatments or causal relation? @BloodJournal ashpublications.org/blood/article/…
Cihan Ay tweet media
English
5
29
98
0
Florian Moik retweetledi
Cihan Ay
Cihan Ay@Cihan_Ay_MD·
@FlorianMoik presents data of his MDPhD project on the role of biomarkers indicating activation of haemostasis/fibrinolysis for prediction of prognosis & oncological outcomes (PFS, chemo response) in pts with pancreatic cancer. Hypercoagulability ➡️bad prognostic factor. #ASH20
Cihan Ay tweet media
English
0
1
0
0
Florian Moik retweetledi
Dino Mehic
Dino Mehic@dino_mehic·
Great talk by my colleague @FlorianMoik on the association of hemostatic biomarkers with mortality in pancreatic cancer #ASH20
Dino Mehic tweet media
English
0
2
4
0

Keşfet

@JTHjournal @liberale_luca @Cihan_Ay_MD @TomLuscher @escardio @KralerSimon @UniGenova @cmc_uzh